{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:31:21Z","timestamp":1792042281153,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003402","name":"Fundaci\u00f3n Valle del Lili","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003402","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tecnoqu\u00edmicas"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-67261-w","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T13:04:03Z","timestamp":1722863043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of aldosterone to direct renin ratio, low renin and related Phenotypes in Afro-Colombian patients with apparent treatment resistant hypertension"],"prefix":"10.1038","volume":"14","author":[{"given":"C. E.","family":"Dur\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Useche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Trivi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Moncayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Hern\u00e1ndez Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schweineberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"issue":"5","key":"67261_CR1","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey, R. M. et al. Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association. Hypertension. 72(5), E53-90 (2018).","journal-title":"Hypertension."},{"issue":"40","key":"67261_CR2","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/eurheartj\/ehv392","volume":"36","author":"SF Rimoldi","year":"2015","unstructured":"Rimoldi, S. F., Messerli, F. H., Bangalore, S. & Scherrer, U. Resistant hypertension: What the cardiologist needs to know. Eur. Heart J. 36(40), 2686\u20132695 (2015).","journal-title":"Eur. Heart J."},{"issue":"2","key":"67261_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/heartjnl-2018-313599","volume":"105","author":"JJ Noubiap","year":"2019","unstructured":"Noubiap, J. J. et al. Global prevalence of resistant hypertension: A meta-analysis of data from 3.2 million patients. Heart. 105(2), 98\u2013105 (2019).","journal-title":"Heart."},{"issue":"5","key":"67261_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41440-020-00579-w","volume":"44","author":"K Nishimoto","year":"2021","unstructured":"Nishimoto, K. et al. Diverse pathological lesions of primary aldosteronism and their clinical significance. Hypertens. Res. 44(5), 498\u2013507 (2021).","journal-title":"Hypertens. Res."},{"issue":"11","key":"67261_CR5","volume":"10","author":"Z Meng","year":"2020","unstructured":"Meng, Z. et al. Long-term mortality for patients of primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis. Front. Endocrinol. (Lausanne). 10(11), 510888 (2020).","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"6","key":"67261_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/CM9.0000000000001906","volume":"135","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Diagnostic value of aldosterone to renin ratio calculated by plasma renin activity or plasma renin concentration in primary aldosteronism: A meta-analysis. Chin. Med. J. (Engl.) 135(6), 639\u2013647 (2022).","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"5","key":"67261_CR7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder, J. W. et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889\u20131916 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"67261_CR8","first-page":"1","volume":"2024","author":"SS Shah","year":"2024","unstructured":"Shah, S. S. et al. Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: A systematic review and meta-analysis. J. Hum. Hypertens. 2024, 1\u201310 (2024).","journal-title":"J. Hum. Hypertens."},{"issue":"5","key":"67261_CR9","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","volume":"69","author":"R Baudrand","year":"2017","unstructured":"Baudrand, R. et al. Continuum of renin-independent aldosteronism in normotension. Hypertension. 69(5), 950\u2013956 (2017).","journal-title":"Hypertension."},{"issue":"9","key":"67261_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M17-0882","volume":"167","author":"JM Brown","year":"2017","unstructured":"Brown, J. M. et al. The spectrum of subclinical primary aldosteronism and incident hypertension: A cohort study. Ann. Intern. Med. 167(9), 630\u2013641 (2017).","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"67261_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","volume":"138","author":"J Brian Byrd","year":"2018","unstructured":"Brian Byrd, J., Turcu, A. F. & Auchus, R. J. Primary aldosteronism: A practical approach to diagnosis and management. Circulation. 138(8), 823 (2018).","journal-title":"Circulation."},{"issue":"9","key":"67261_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/ajh\/hpx066","volume":"30","author":"A Akintunde","year":"2017","unstructured":"Akintunde, A. et al. Physiological phenotyping for personalized therapy of uncontrolled hypertension in Africa. Am. J. Hypertens. 30(9), 923\u2013930 (2017).","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"67261_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.116.08484","volume":"69","author":"TD Wang","year":"2017","unstructured":"Wang, T. D. et al. Effects of sacubitril\/valsartan (LCZ696) on natriuresis, diuresis, blood pressures, and NT-proBNP in salt-sensitive hypertension. Hypertension. 69(1), 32\u201341 (2017).","journal-title":"Hypertension."},{"key":"67261_CR14","doi-asserted-by":"publisher","first-page":"100750","DOI":"10.1016\/j.eclinm.2021.100750","volume":"33","author":"N Graudal","year":"2021","unstructured":"Graudal, N., Hubeck-Graudal, T. & Jurgens, G. Influence of sodium intake and change in sodium intake on plasma-renin in man. EClinicalMedicine. 33, 100750 (2021).","journal-title":"EClinicalMedicine."},{"key":"67261_CR15","unstructured":"Urrea-Giraldo, F., Felipe, A. & \u00c1lvarez, C. Cali, ciudad regi\u00f3n ampliada: una aproximaci\u00f3n desde la dimensi\u00f3n \u00e9tnica-racial y los flujos poblacionales 1 Cali, an enlarged region city: an approximation from the ethnic-racial dimension and population flows Cali, cidade regi\u00e3o ampliada: uma aproxima\u00e7\u00e3o desde a dimens\u00e3o \u00e9tnica-racial e dos fluxos populacionais."},{"issue":"7","key":"67261_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/ajh\/hpac051","volume":"35","author":"JP Lopez-Lopez","year":"2022","unstructured":"Lopez-Lopez, J. P. et al. Ethnic differences in the prevalence of hypertension in Colombia: Association with education level. Am. J. Hypertens. 35(7), 610\u2013618 (2022).","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"67261_CR17","first-page":"241","volume":"18","author":"J Lindhorst","year":"2007","unstructured":"Lindhorst, J., Alexander, N., Blignaut, J. & Rayner, B. Differences in hypertension between blacks and whites: An overview. Cardiovasc. J. Afr. 18(4), 241 (2007).","journal-title":"Cardiovasc. J. Afr."},{"issue":"1","key":"67261_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1440-1681.1993.tb01496.x","volume":"20","author":"T Kawasaki","year":"1993","unstructured":"Kawasaki, T., Itoh, K., Uezono, K. & Sasaki, H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin. Exp. Pharmacol. Physiol. 20(1), 7\u201314 (1993).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"67261_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/cen.13741","volume":"89","author":"S Monticone","year":"2018","unstructured":"Monticone, S. et al. Diagnostic approach to low-renin hypertension. Clin. Endocrinol. (Oxf). 89(4), 385\u2013396 (2018).","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"4","key":"67261_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4067\/S0034-98872019000400490","volume":"147","author":"S Macchiavello","year":"2019","unstructured":"Macchiavello, S. et al. Actualizaci\u00f3n en el manejo cl\u00ednico de la hipertensi\u00f3n hiporrenin\u00e9mica. Rev. Med. Chil. 147(4), 490\u2013498 (2019).","journal-title":"Rev. Med. Chil."},{"issue":"11","key":"67261_CR21","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1111\/bcp.13706","volume":"84","author":"V Avataneo","year":"2018","unstructured":"Avataneo, V. et al. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br. J. Clin. Pharmacol. 84(11), 2535 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"67261_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1681\/ASN.2011040430","volume":"23","author":"S Vegter","year":"2012","unstructured":"Vegter, S. et al. Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23(1), 165\u2013173 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67261_CR23","unstructured":"Laurent, S. et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension."},{"issue":"4","key":"67261_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.kint.2023.06.035","volume":"104","author":"L Vogt","year":"2023","unstructured":"Vogt, L., Marques, F. Z., Fujita, T., Hoorn, E. J. & Danser, A. H. J. Novel mechanisms of salt-sensitive hypertension. Kidney Int. 104(4), 690\u2013697 (2023).","journal-title":"Kidney Int."},{"issue":"3","key":"67261_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/HYPERTENSIONAHA.120.14481","volume":"77","author":"SM Mutchler","year":"2021","unstructured":"Mutchler, S. M., Kirabo, A. & Kleyman, T. R. Epithelial sodium channel and salt-sensitive hypertension. Hypertension. 77(3), 759\u2013767 (2021).","journal-title":"Hypertension."},{"issue":"4","key":"67261_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.krcp.2016.07.004","volume":"35","author":"SK Bhandari","year":"2016","unstructured":"Bhandari, S. K., Batech, M., Shi, J., Jacobsen, S. J. & Sim, J. J. Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure. Kidney Res. Clin. Pract. 35(4), 219\u2013228 (2016).","journal-title":"Kidney Res. Clin. Pract."},{"issue":"3","key":"67261_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.ackd.2014.11.006","volume":"22","author":"EC Ray","year":"2015","unstructured":"Ray, E. C., Rondon-Berrios, H., Boyd, C. R. & Kleyman, T. R. Sodium retention and volume expansion in nephrotic syndrome: Implications for hypertension. Adv. Chronic Kidney Dis. 22(3), 179\u2013184 (2015).","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"6","key":"67261_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero, P. et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 40(6), 897\u2013902 (2002).","journal-title":"Hypertension."},{"issue":"6","key":"67261_CR29","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/HYPERTENSIONAHA.115.07061","volume":"67","author":"V Nesterov","year":"2016","unstructured":"Nesterov, V. et al. In liddle syndrome, epithelial sodium channel is hyperactive mainly in the early part of the aldosterone-sensitive distal nephron. Hypertension. 67(6), 1256\u20131262 (2016).","journal-title":"Hypertension."},{"issue":"6","key":"67261_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(18)30080-9","volume":"6","author":"DA Calhoun","year":"2018","unstructured":"Calhoun, D. A. Fluid retention, aldosterone excess, and treatment of resistant hypertension. Lancet Diabetes Endocrinol. 6(6), 431\u2013433 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"67261_CR31","doi-asserted-by":"publisher","first-page":"F325","DOI":"10.1152\/ajprenal.00415.2020","volume":"320","author":"Z Gray","year":"2021","unstructured":"Gray, Z., Tu, W., Chertow, G. M. & Bhalla, V. Aldosterone sensitivity: An opportunity to explore the pathogenesis of hypertension. Am. J. Physiol. Renal Physiol. 320(3), F325\u2013F335 (2021).","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"8","key":"67261_CR32","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","volume":"79","author":"AA Leung","year":"2022","unstructured":"Leung, A. A. et al. Performance of confirmatory tests for diagnosing primary aldosteronism: A systematic review and meta-analysis. Hypertension. 79(8), 1835 (2022).","journal-title":"Hypertension."},{"issue":"2","key":"67261_CR33","first-page":"607","volume":"72","author":"S Jd","year":"2018","unstructured":"Jd, S. & Bl, R. Hypertension in blacks: Individualized therapy based on renin\/aldosterone phenotyping. Hypertension. 72(2), 607\u2013622 (2018).","journal-title":"Hypertension."},{"issue":"5","key":"67261_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ajh\/hpw167","volume":"30","author":"ES Jones","year":"2017","unstructured":"Jones, E. S. et al. High frequency of variants of candidate genes in black Africans with low renin-resistant hypertension. Am. J. Hypertens. 30(5), 478\u2013483 (2017).","journal-title":"Am. J. Hypertens."},{"issue":"7","key":"67261_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ajh.2009.63","volume":"22","author":"BM Egan","year":"2009","unstructured":"Egan, B. M. et al. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: A randomized controlled trial. Am. J. Hypertens. 22(7), 792\u2013801 (2009).","journal-title":"Am. J. Hypertens."},{"issue":"8","key":"67261_CR36","first-page":"31","volume":"70","author":"MSN Murty","year":"2022","unstructured":"Murty, M. S. N. et al. Plasma renin-guided therapy in patients of primary hypertension on antihypertensives: A prospective cohort study. J. Assoc. Phys. India. 70(8), 31\u201336 (2022).","journal-title":"J. Assoc. Phys. India."},{"issue":"4","key":"67261_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.23876\/j.krcp.21.800","volume":"40","author":"J Shin","year":"2021","unstructured":"Shin, J. & Lee, C. H. The roles of sodium and volume overload on hypertension in chronic kidney disease. Kidney Res. Clin. Pract. 40(4), 542 (2021).","journal-title":"Kidney Res. Clin. Pract."},{"issue":"9","key":"67261_CR38","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.3390\/ijms24097775","volume":"24","author":"R Lemmens-Gruber","year":"2023","unstructured":"Lemmens-Gruber, R. & Tzotzos, S. The epithelial sodium channel\u2014An underestimated drug target. Int. J. Mol. Sci. 24(9), 7775 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"67261_CR39","doi-asserted-by":"crossref","unstructured":"Brown, M. J. et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): A parallel-group, double-blind randomised phase 4 trial. http:\/\/www.thelancet.com\/diabetes-endocrinology (2016).","DOI":"10.1016\/S2213-8587(15)00377-0"},{"key":"67261_CR40","first-page":"1","volume":"2018","author":"L Ma","year":"2018","unstructured":"Ma, L. et al. Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening. Int. J. Endocrinol. 2018, 1\u201310 (2018).","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"67261_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41371-018-0112-8","volume":"33","author":"W Gan","year":"2019","unstructured":"Gan, W. et al. High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism. J. Hum. Hypertens. 33(1), 57\u201361 (2019).","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"67261_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/HJH.0000000000000076","volume":"32","author":"C Lonati","year":"2014","unstructured":"Lonati, C., Bassani, N., Gritti, A., Biganzoli, E. & Morganti, A. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. J. Hypertens. 32(3), 627\u2013634 (2014).","journal-title":"J. Hypertens."},{"key":"67261_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4634823","volume":"2019","author":"T Li","year":"2019","unstructured":"Li, T. et al. Feasibility of screening primary aldosteronism by aldosterone-to-direct renin concentration ratio derived from chemiluminescent immunoassay measurement: Diagnostic accuracy and cutoff value. Int. J. Hypertens. 2019, 1\u20138 (2019).","journal-title":"Int. J. Hypertens."},{"issue":"1","key":"67261_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41371-020-00465-5","volume":"36","author":"K Teruyama","year":"2022","unstructured":"Teruyama, K., Naruse, M., Tsuiki, M. & Kobayashi, H. Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism. J. Hum. Hypertens. 36(1), 77 (2022).","journal-title":"J. Hum. Hypertens."},{"issue":"2","key":"67261_CR45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/HYPERTENSIONAHA.117.09078","volume":"70","author":"R Morimoto","year":"2017","unstructured":"Morimoto, R. et al. Rapid screening of primary aldosteronism by a novel chemiluminescent immunoassay. Hypertension. 70(2), 334\u2013341 (2017).","journal-title":"Hypertension."},{"issue":"1","key":"67261_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","volume":"32","author":"PM Jansen","year":"2014","unstructured":"Jansen, P. M. et al. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism. J. Hypertens. 32(1), 115\u2013126 (2014).","journal-title":"J. Hypertens."},{"issue":"41","key":"67261_CR47","first-page":"3250","volume":"100","author":"W Ma","year":"2020","unstructured":"Ma, W. et al. Application of aldosterone\/direct renin ratio before drug washout in the screening of primary aldosteronism. Zhonghua Yi Xue Za Zhi. 100(41), 3250\u20133254 (2020).","journal-title":"Zhonghua Yi Xue Za Zhi."},{"key":"67261_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3934212","volume":"2020","author":"W Lin","year":"2020","unstructured":"Lin, W. et al. High efficiency and problems of chemiluminescence assay-detected aldosterone-to-renin ratio in practical primary aldosteronism screening. Int. J. Hypertens. 2020, 1\u20136 (2020).","journal-title":"Int. J. Hypertens."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67261-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T14:03:08Z","timestamp":1722866588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67261-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67261"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67261-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18091"}}